一个重大进展更新:表皮生长因子受体抑制剂作为有效的抗癌剂
Neha Jangra1, Bharti Sharma1, Deepak Kumar1
1Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology Hisar-125001 India nehajangra9728@gmail.com bhartis4444@gmail.com deepak.kr.dk74@gmail.com kapoorarchana06@gmail.com.
本综述总结了最近在开发选择性表皮生长因子受体 (EGFR) 抑制剂方面的进展. 它突出了针对癌症治疗的新型化学型和结构类,旨在提高疗效和减少副作用.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 表皮生长因子受体 (EGFR) 家族在细胞信号传递中至关重要,调节诸如增殖和转移等过程.
- 目前的EGFR抑制剂缺乏选择性,导致显著的副作用和治疗挑战.
- 开发向EGFR抑制剂对于有效的癌症疗法至关重要,特别是乳腺和肺部瘤.
研究的目的:
- 审查最近 (2016-2024) 对各种EGFR抑制剂的研究和开发.
- 专注于新的化学类型,包括pyrrole,indole,pyrimidine,oxadiazole和isoxazole衍生物.
- 为发现具有增强疗效和选择性的新EGFR抑制剂提供指导.
主要方法:
- 编制临床前和临床数据.
- 结构-活动关系 (SAR) 的分析.
- 包括基于机制的和in silico研究结果.
主要成果:
- 识别不同的结构类 (醇,醇,胺,等等). 作为潜在的EGFR抑制剂.
- 在开发选择性EGFR抑制剂方面取得的进展概述.
- 为新型化合物设计编制SAR和in silico数据.
结论:
- 最近的研究为EGFR抑制剂的发展提供了有前途的新型化学型.
- 有针对性的EGFR抑制有可能提高癌症治疗的有效性和安全性.
- 对这些结构类的持续探索将推动下一代癌症治疗的发现.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
相关概念视频
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
